相关实验视频

Updated: Jul 6, 2026

An In Vitro Approach to Photodynamic Therapy

An In Vitro Approach to Photodynamic Therapy

Published on: August 17, 2018

用光动力学疗法成功治疗皮肤莱什曼病:一个病例系列

Federica Li Pomi¹, Valeria Papaianni², Marta Vitale²

¹Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), University of Palermo, 90127, Palermo, Italy.

Photodiagnosis and photodynamic therapy

|January 12, 2026

概括

光动力疗法 (PDT) 为皮肤莱什曼病 (CL) 提供了一种安全有效的治疗方法. 传统和白天PDT协议都实现了完全的病变清除,最小的不适和良好的化品效果.

科学领域:

皮肤病学皮肤病学
寄生虫学的寄生虫学
照相医疗 (photomedicine) 是一种医学.

背景情况:

皮肤莱什曼病 (CL) 是一种由传播的寄生虫皮肤感染,引起各种皮肤病变.
目前对CL的治疗有局限性,包括毒性,侵入性和患者不良服药性,特别是在儿童中.

研究的目的:

评估光动力学疗法 (PDT) 的疗效,安全性和耐受性,用于成人和儿科患者治疗CL.
为了比较传统的PDT (C-PDT) 和白天PDT (DL-PDT) 协议.

主要方法:

一项回顾性研究涉及9名PCR确认的CL患者 (4名儿科,5名成年人),接受每月3次PDT治疗,使用5-氨基诺列武林酸 (ALA).
使用视觉模拟尺度 (VAS) 评估疼痛;监测不良事件和临床结果.

主要成果:

在所有患者中都实现了完整的病变清除,没有复发和良好的化品结果.
与传统PDT (C-PDT) 相比,日光PDT (DL-PDT) 的中位数VAS疼痛得分 (1) 显著较低 (6).
仅观察到轻度,短暂的红疹;没有发生系统性不良事件.

结论:

无论是C-PDT还是DL-PDT都是CL的安全,有效和耐受良好的治疗选择.
由于PDT的非侵入性和最小的不适使其适用于儿科和疼痛敏感患者.

关键词:

在PDT中使用PDT.对抗微生物的PDT.孩子孩子孩子孩子孩子孩子皮肤上的莱什曼病.在白天 PDT 的 PDT.

更多相关视频

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation

Published on: January 24, 2025

Development of an Innovative LED-based Illumination Device for In Vitro Application of Photodynamic Therapy with Rose Bengal

Development of an Innovative LED-based Illumination Device for In Vitro Application of Photodynamic Therapy with Rose Bengal

Published on: September 12, 2025

相关概念视频

Leishmaniasis

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...

Antiprotozoal Agents

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...